Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,479 INR | -0.52% | +5.31% | +18.64% |
May. 27 | Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research | RE |
May. 23 | Nomura Adjusts Cipla’s Price Target to INR1,535 From INR1,486, Keeps at Neutral | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.64% | 14.45B | |
+16.40% | 42.95B | |
+17.22% | 21.38B | |
+20.14% | 15.05B | |
+53.58% | 13.04B | |
-0.05% | 6.79B | |
-11.82% | 6.72B | |
-8.87% | 5.73B | |
+11.64% | 5.47B | |
+7.31% | 4.84B |
- Stock Market
- Equities
- CIPLA Stock
- News Cipla Limited
- Cipla's Consolidated Net Profit Climbs in Fiscal Q4; Shares Up 6%